Autism Research Institute

From WikiMD's WELLNESSPEDIA

Autism Research Institute (ARI) is a non-profit organization that focuses on conducting and promoting research on the causes of autism and on methods of preventing, diagnosing and treating autism and other severe behavioral disorders of childhood. The institute was founded in 1967 by Dr. Bernard Rimland, a research psychologist and father of a child with autism.

History[edit]

The Autism Research Institute was established with the aim of providing resources and conducting research to improve the quality of life for individuals with autism. Dr. Bernard Rimland, the founder of ARI, was instrumental in changing the perception of autism from a condition caused by poor parenting to a neurological disorder. His book, Infantile Autism: The Syndrome and Its Implications for a Neural Theory of Behavior, was one of the first major works to argue that autism is a biological condition.

Research[edit]

ARI conducts and sponsors research on various aspects of autism, including its causes, prevention, and treatment. The institute has been involved in several significant studies, such as the Autism Treatment Evaluation Checklist (ATEC) and the Defeat Autism Now! (DAN!) protocol. ARI also maintains a comprehensive database of autism research, which is available to the public.

Programs and Services[edit]

The Autism Research Institute offers a variety of programs and services to support individuals with autism and their families. These include educational resources, webinars, and a free online newsletter. ARI also provides information on autism treatment options and maintains a list of doctors who specialize in autism treatment.

Criticism and Controversy[edit]

While ARI's research and programs have been beneficial to many, they have also faced criticism. Some of the treatments promoted by ARI, such as chelation therapy and hyperbaric oxygen therapy, have been controversial due to lack of scientific evidence and potential risks.

See Also[edit]

References[edit]



Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Autism_Research_Institute&oldid=6615617"